Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211379 · ClinicalTrials.gov registry record · NA
The FLU-FOBT Program in Primary Care Settings Where Disparities Persist
A NA study of Colorectal Cancer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,372
- Enrollment target
- 1
- Study location
NCT01211379: Completed NA study of Colorectal Cancer, sponsored by University of California, San Francisco.
NCT01211379 is a NA study of Colorectal Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 1,372 participants, below the 1,541-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211379, a NA study of Colorectal Cancer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,372 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (FOBT) are provided with influenza vaccinations (FLU) to eligible patients between the ages of 50 and 75 during FLU season. The investigators hypothesis is that the FLU-FOBT Program can be adapted for primary care settings and lead to higher rates of colorectal cancer screening (CRCS).
Primary Outcome
Change in colorectal cancer screening rates (defined as being up to date with FOBT in the last 12 months, up to date with flexible sigmoidoscopy within the last 5 years, or up to date with colonoscopy in the last 10 years) by March 30, 2010, 6 months after the beginning of the intervention.
Conditions Studied
Interventions
- BEHAVIORAL FLU-FOBT Program
Study Locations (1)
California
- San Francisco Department of Public Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,372 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT01211379 record still lists
NCT01211379 is an interventional study that assigns participants to a tested intervention. Its 1,372 participants enrollment target places it among the larger protocols in the corpus, below the 1,541-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which FLU-FOBT Program is the first listed.
NCT01211379 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01211379 about?
NCT01211379 is a clinical study titled "The FLU-FOBT Program in Primary Care Settings Where Disparities Persist". The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (F...
What is the current status of trial NCT01211379?
This trial is currently completed. It is a NA study. The enrollment target is 1,372 participants. The study started on 2009-10. Estimated completion is 2010-08.
What conditions does trial NCT01211379 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT01211379?
The interventions under investigation include: FLU-FOBT Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01211379?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01211379 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01211379's enrollment target sits among peer trials
1,372 37th of 381 higher than 345 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia